References
- van der Putten AB, Bijleveld CM, Slooff MJ, Wesenhagen H, Gips CH. Selection criteria and decisions in 375 patients with liver disease, considered for liver transplantation during 1977-1985. Liver 1987;7:84-90.
- O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988;207:373-379. https://doi.org/10.1097/00000658-198804000-00002
- Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993;218:145-151. https://doi.org/10.1097/00000658-199308000-00005
- Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699. https://doi.org/10.1056/NEJM199603143341104
- Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Trasnpl 2002;8:765-774. https://doi.org/10.1053/jlts.2002.34892
- Lee SG, Hwang S, Moon DB, et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl 2008;14:935-945. https://doi.org/10.1002/lt.21445
- Kwon CH, Kim DJ, Han YS, et al. HCC in living donor liver transplantation: can we expand the Milan criteria? Dig Dis 2007;25:313-319. https://doi.org/10.1159/000106911
- Suh KS, Cho EH, Lee HW, Shin WY, Yi NJ, Lee KU. Liver trnasplantation for hepatocellular carcinoma in patients who do not meet Milan criteria. Dig Dis 2007;25:329-333. https://doi.org/10.1159/000106913
- Ito T, Takada Y, Ueda M, et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007;13:1637-1644. https://doi.org/10.1002/lt.21281
- Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007;25:310-312. https://doi.org/10.1159/000106910
- Soejima Y, Taketomi A, Yoshizumi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007;83:893-899. https://doi.org/10.1097/01.tp.0000259015.46798.ec
- Lee SG, Ahn CS, Ha TY, et al. Liver transplantation for hepatocellular carcinoma: Korean experience. J Hepatobiliary Pancreat Surg 2009 [Epub ahead of print].
- Moon DB, Lee SG. Liver transplantation. Gut and liver 2009;3:145-165. https://doi.org/10.5009/gnl.2009.3.3.145
- Moon DB, Lee SG, Hwang S. Liver transplantation for hepatocellular carcinoma: single nodule with Child-Pugh class A sized less than 3 cm. Dig Dis 2007;25:320-328. https://doi.org/10.1159/000106912
- Gondolesi GE, Roayaie S, Munoz L, et al. Adult living donor liver transplantation for patient hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004;239:142-149. https://doi.org/10.1097/01.sla.0000109022.32391.eb
- Lo CM, Fan ST, Liu CL, Chan SC, Wong J. The role and limitation of living donor liver transplantation. Liver Transpl 2004;10:440-447. https://doi.org/10.1002/lt.20097
- Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007;94:78-86. https://doi.org/10.1002/bjs.5528
- Hiatt JR, Carmody IC, Busuttil RW. Should we expand the criteria for hepatocellular carcinoma with living donor liver transplantation? -no, never. J Hepatol 2005;43:573-577. https://doi.org/10.1016/j.jhep.2005.07.017
- Marcos A, Fisher RA, Ham JM, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69:1375-1379. https://doi.org/10.1097/00007890-200004150-00028
- Drixler TA, Vogten MJ, Ritchie ED, et al. Liver regeneration is anangiogenesis-associated phenomenon. Ann Surg 2002;236:703-712. https://doi.org/10.1097/00000658-200212000-00002
- Todo S, Furukawa H. The Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004;240:451-459. https://doi.org/10.1097/01.sla.0000137129.98894.42
- Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl 2005;11:1265-1272. https://doi.org/10.1002/lt.20549
- Hwang S, Lee SG, Belghiti J. Liver transplantation for HCC: its role. Eastern and western perspectives. J Hepatobiliary Pancreat Surg 2009 (Epub ahead of print)
- Yao FY, Ferrel L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403. https://doi.org/10.1053/jhep.2001.24563
- Yao FY, Bass NM, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from waiting list. Liver Transpl 2002;8:873-883. https://doi.org/10.1053/jlts.2002.34923
- Furukawa H, Shimamura T, Suzuki T, et al. Liver transplantation for hepatocellular carcinoma: the Japanese experience. J Hepatobiliary Pancreat Surg 2009 [Epub ahead of print].
- Trotter JF, Adam R, Lo CM, Kenison J. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl 2006;12:1485-1488. https://doi.org/10.1002/lt.20875
- Lo CM, Fan ST, Liu CL, et al. Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg 2004;240:151-158. https://doi.org/10.1097/01.sla.0000129340.05238.a0
- Hwang S, Lee SG, Lee YJ, et al. Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl 2006;12:920-927. https://doi.org/10.1002/lt.20734
- Marsh JW, Gray E, Ness R, Starzl TE. Complications of right lobe living donor liver transplantation. J Hepatol 2009;51:715-724. https://doi.org/10.1016/j.jhep.2009.04.023
- Bruix J, Fuster J, Llovet JM. Liver transplantation for heptocellular carcinoma: foucault pendulum versus evidence-based decision. Liver Transpl 2003;9:700-702. https://doi.org/10.1053/jlts.2003.50124
- Cillo U, Vitale A, Bassanello M, et al. Liver transplantation for the treatment for moderately and well-differentiated hepatocellular carcinoma. Ann Surg 2004;239:150-159. https://doi.org/10.1097/01.sla.0000109146.72827.76
- Marshall AE, Rushbrook SM, Voeler SL, et al. Tumor recurrence following liver transplantation for hepatocellular carcinoma: role of tumor proliferation status. Liver Transpl 2010;16:279-288. https://doi.org/10.1002/lt.21993
- Durand F, Regimbeau JM, Belghiti J, et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 2001;35:254-258. https://doi.org/10.1016/S0168-8278(01)00108-8
- Perkins JD. Seeding risk following percutaneous approach to hepatocellular carcinoma. Liver Transpl 2007;13:1603-1607. https://doi.org/10.1002/lt.21315
- Han K, Tzimas GN, Barkun JS, et al. Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. Can J Gastroenterol 2007;21:39-45. https://doi.org/10.1155/2007/206383
- Nanashima A, Morino S, Yamaguchi H, et al. Modified CLIP using PIVKA-II for evaluating prognosis after hepatoctomy for hepatocellular carcinoma. Eur J Surg Oncol 2003;29:735-742. https://doi.org/10.1016/j.ejso.2003.08.007
- Taketomi A, Sanefuji K, Soejima Y, et al. Impact of desgamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 2009;87:531-537. https://doi.org/10.1097/TP.0b013e3181943bee
- Hatano E, Ikai I, Higashi T, et al. Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection. World J Surg 2006;30:1736-1741. https://doi.org/10.1007/s00268-005-0791-5
- Yang SH, Suh KS, Lee HW, et al. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl 2006;12:1655-1660. https://doi.org/10.1002/lt.20861
- Yang SH, Suh KS, Lee HW, et al. A revised scoring system utilizing serum alphafetoprotein level to expand candidates for living donor liver transplantation in hepatocellular carcinoma. Surgery 2007;141:598-609. https://doi.org/10.1016/j.surg.2006.11.006
- Voulgari A, Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 2009;1796:75-90.
- Lee JS, Chu IS, Heo J, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004;40:667-676. https://doi.org/10.1002/hep.20375
- Lubienski A. Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation 2005;80(suppl 1):S113-S119. https://doi.org/10.1097/01.tp.0000187109.69663.93
- Yao FY, Kerlan RK Jr, Hirose R, et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008;48:819-827. https://doi.org/10.1002/hep.22412
- Soderdahl G, Backman L, Isoniemi H, et al. A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma. Transpl Int 2006;19:288-294. https://doi.org/10.1111/j.1432-2277.2006.00279.x
- Porrett PM, Peterman H, Rosen M, et al. Lack of benefit of pretransplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl 2006;12:665-673. https://doi.org/10.1002/lt.20636
- Decaens T, Roudot-Thoraval F, Bresson-Hadni S, et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005;11:767-775. https://doi.org/10.1002/lt.20418
- Perez Saborido B, Meneu JC, Moreno E, et al. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma? Am J Surg 2005;190:383-387. https://doi.org/10.1016/j.amjsurg.2005.06.001
- Adam R, Azoulay D, Castaing D, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 2003;238:508-519.
- Belghiti J, Cortes A, Abdalla EK, et al. Resection prior to liver resection for hepatocellular carcinoma. Ann Surg 2003;238:885-893. https://doi.org/10.1097/01.sla.0000098621.74851.65
- Hwang S, Lee SG, Moon DB, et al. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl 2007;13:741-746. https://doi.org/10.1002/lt.21157
- Schlitt HJ, Neipp M, Weimann A, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma aftre liver transplantation. J Clin Oncol 1999;17:324-331. https://doi.org/10.1200/JCO.1999.17.1.324
- Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991;68:2095-2100. https://doi.org/10.1002/1097-0142(19911115)68:10<2095::AID-CNCR2820681002>3.0.CO;2-Y
- Kornberg A, Küpper B, Tannapfel A, et al. Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables. Eur J Surg Oncol 2010;36:275-280. https://doi.org/10.1016/j.ejso.2009.10.001
- Taketomi A, Fukuhara T, Morita K, et al. Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation. Ann Surg Oncol 2010 [Epub ahead of print].
- Valdivieso A, Bustamante J, Gastaca M, et al. Management of hepatocellular carcinoma recurrence after liver transplantation. Transplant Proc 2010;42:660-662. https://doi.org/10.1016/j.transproceed.2010.02.014
- Roayaie S, Schwarts JD, Sung MW, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns of prognosis. Liver Transpl 2004:10:534-540. https://doi.org/10.1002/lt.20128
- Lee JO, Kim DY, Lim JH, et al. Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation. J Gastroenterol Hepatol 2009;24:800-805. https://doi.org/10.1111/j.1440-1746.2008.05672.x
- Vivarelli M, Cucchetti A, Piscaglia F, et al. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. Liver Transpl 2005;11:497-503. https://doi.org/10.1002/lt.20391
- Vivarelli M, Cuccetti A, La Barba G, et al. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. Ann Surg 2008;248:857-862. https://doi.org/10.1097/SLA.0b013e3181896278
- Wang Z, Zhou J, Fan J, et al. Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma. J Cancer Res Clin Oncol 2009;135:715-722. https://doi.org/10.1007/s00432-008-0506-z
- Toso C, Meeberg GA, Bigam DL, et al. De novo sirolimusbased immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation 2007;83:1162-1168. https://doi.org/10.1097/01.tp.0000262607.95372.e0
Cited by
- 韓国における肝移植の現状 vol.52, pp.2, 2011, https://doi.org/10.2957/kanzo.52.150
- Early Steroid Withdrawal Regimen Prevents New-Onset Diabetes Mellitus in Old-Age Recipients After Living Donor Liver Transplantation vol.36, pp.10, 2012, https://doi.org/10.1007/s00268-012-1661-6
- Living Donor Liver Transplantation in a Hepatitis B Patient with Acute on Chronic Liver Failure Accompanying Hepatocellular Carcinoma vol.39, pp.3, 2010, https://doi.org/10.12771/emj.2016.39.3.76
- 간이식 환자의 뇌경색에 대한 한의학적 치료 증례보고 vol.24, pp.3, 2010, https://doi.org/10.14374/hfs.2016.24.3.225